While mice experiments highlighted that the inhibition of specific Cers genes could be a targeted approach for the treatment of obesity and type 2 diabetes mellitus [82], an oral administration of rice-derived GlcCers could compensate for the epidermal loss of Cer [54]. The gene discussed is CBLN1; the disease is obesity due to melanocortin 4 receptor deficiency.